Medicated Ecosystems: Human Drugs Alter Key Aquatic Organism

In the last decade, European and American researchers have found more evidence that lakes and streams are tainted by common drugs, ranging from caffeine to anticancer agents.

This pollution, says Colleen Flaherty, a UW-Madison zoologist, has direct ties to humans, either through the improper disposal of unwanted pharmaceuticals or through the ingestion of the drugs.

"Up to 80 percent of drugs taken by humans and domesticated animals can be excreted in their biologically active form," explains Flaherty. This means that the antibiotics, antidepressants and anti-inflammatory pills we either take or throw out can eventually end up polluting the environment and harming the organisms that live in it.

Says UW-Madison zoologist Stanley Dodson, who studies freshwater ecology, "Pharmaceuticals can be detected in many surface water streams and lakes, yet we know little about how these strongly biologically active chemicals affect the ecology of aquatic organisms."

Flaherty will present findings from her study -- one of the first to document the effects of commonly-prescribed drugs on Daphnia, a zooplankton integral to freshwater ecosystems -- Thursday, Aug. 7, at the annual meeting of the Ecological Society of America.

"Daphnia play a key ecological role in freshwater sources," says Flaherty. "They are an intermediate organism in these ecosystems -- they eat the algae and are eaten by the fish. If something happens to Daphnia, it could affect both the algae and the fish populations."

To determine the influence of pharmaceuticals on this key freshwater species, Flaherty tested Daphnia's biological response to commonly prescribed drugs that have been found in European and U.S. waters; the drugs include a cholesterol-lowering one (clofibric acid), an antidepressant (fluoxetine) and five antibiotics.

Flaherty performed short- and long-term studies to find out what happens to a female Daphnia and her offspring when exposed to a particular drug. Flaherty measured the survival, growth, number and sex of each female's offspring. While the short-term studies looked at a single brood, the long-term ones examined all the offspring the female produced during her life span (about 30 days).

The effects Flaherty found varied. In the short-term studies, the antibiotics and cholesterol drug at concentrations of just 10 parts per billion -- an environmentally relevant concentration, says Flaherty -- appear to stunt growth and result in more male offspring.

In the long-term studies, these differences were diminished: offspring exposed to the antibiotics tended to have longer lifespans; those exposed to the cholesterol-lowering drug showed no apparent effects. While the other drug, an antidepressant, produced no differences in the shorter trials, it did result in a greater number of offspring in the longer studies.

"When Daphnia were exposed to a single pharmaceutical throughout their entire lifespan, as in the long-term studies, they seemed to become acclimated to the polluted environment," Flaherty says.

But, as Flaherty points out, Daphnia swim in waters tainted with not just one drug, but many: "Some of these drugs may not have significant effects by themselves," she says, "but, when you combine them in a 'pharmaceutical cocktail,' the effects can be lethal."

When Flaherty exposed the organisms to a combination of the cholesterol drug and the antidepressant during the short-term studies, she found that the offspring were more likely to be female, have more deformities that hinder swimming and up to a 90 percent mortality rate. Flaherty says, "I never expected that two drugs that had virtually no individual effects could be so lethal when combined."

Because of these findings, Flaherty says that, in order to fully understand the ecological effects of pharmaceuticals or other man-made chemicals on freshwater ecosystems, scientists should look at not just one chemical, but combinations of them.